ClinicaSpace.com
Clinical Research
News & Careers
 
Search the Site
    
 
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login   

By Industry | By Industry Segment | By Services and Suppliers | By Location | Profile Search
 Company Profile

 

European Medicines Agency 

7 Westferry Circus
Canary Wharf
London    E14 4HB  United Kingdom
Phone: 44-0-20-7523-7600 Fax: n/a


SEARCH JOBS


Industry
Services






 Company News
European Medicines Agency Release: Novartis AG (NVS)'s Zykadia Recommended For Approval In Advanced Non Small Cell Lung Cancer 2/27/2015 9:31:17 AM
Amgen (AMGN) Announces The European Medicines Agency Acceptance Of Kyprolis (Carfilzomib) Marketing Authorization Application For The Treatment Of Relapsed Multiple Myeloma 2/27/2015 6:49:51 AM
Tolero Pharmaceuticals Receives European Medicines Agency Orphan Drug Designation For Alvocidib For The Treatment Of Acute Myeloid Leukemia 2/26/2015 6:46:16 AM
Celltrion Healthcare: Data Show The World’s First European Medicines Agency-Approved Biosimilar Monoclonal Antibody Remsima Could Reduce Cost Of Treating Crohn’s Disease By Up To €336 Million Over Five Years 2/20/2015 9:04:24 AM
aTyr Pharma Inc. Receives European Medicines Agency Orphan Drug Designation For Resolaris In FSHD 2/18/2015 8:02:59 AM
THERAVECTYS Obtains Orphan Drug Designation From European Medicines Agency For Its Lentiviral Vector-Based Therapeutic Vaccine Against Adult T-Cell Leukemia And Lymphoma 2/5/2015 9:43:53 AM
GVK Biosciences: European Medicines Agency Recommends Suspending Medicines Over Flawed Studies 1/23/2015 4:08:11 PM
European Medicines Agency Accepts Samsung Bioepis' Enbrel® Biosimilar Candidate, SB4, For Regulatory Review 1/21/2015 10:48:28 AM
PsiOxus Therapeutics Limited Release: European Medicines Agency Grants Positive Opinion For Orphan Drug Status For Ovarian Cancer Oncolytic Vaccine 1/13/2015 11:01:11 AM
Regeneron (REGN) And Sanofi (SAN.PA) Announce Praluent™ (alirocumab) Marketing Authorization Application Has Been Accepted For Review By European Medicines Agency 1/12/2015 7:09:00 AM
12345678910...